Trial intelligence / Profile preview

Chlorhexidine mouthwash in head and neck cancer surgery

NCT02753387Phase 3Completed

Sponsor
CHU Rennes
Start
May 2016
Primary completion
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of chlorhexidine in surgical site infection (SSI) (2 arms), sponsored by CHU Rennes. Primary endpoint: Percentage of patients with pharyngeal mucosa colonization. Started May 2016; status: completed.

02

Drugs

chlorhexidine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT02753387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02753387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call